You searched for Alzheimer's

Best in Biotech 12 Jun 2023

Six advancements in Alzheimer’s research over the past year

…Alzheimer’s. As we observe Alzheimer’s & Brain Awareness Month in June, here are six recent advancements that could transform Alzheimer’s research. Table of contents Coya Therapeutics shows Treg cells can…

June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

…on the Alzheimer’s drug industry as a whole. Aduhelm: the first big Alzheimer’s drug controversy of the decade In 2021, Aduhelm – developed by Biogen and Eisai – was granted…

October 26, 2023 - 11 minutesmins - By Willow Shah-Neville

Biogen's transition from Aduhelm to Leqembi: a new chapter in Alzheimer's drug development

In Depth 15 Feb 2024

Biogen: how is the biotech giant pivoting from a failed Alzheimer’s drug?

…Leqembi represents a significant development in Alzheimer’s treatment for both Biogen and the broader Alzheimer’s community. The FDA granted traditional approval to Leqembi for the treatment of Alzheimer’s disease after…

February 15, 2024 - 11 minutesmins - By Jules Adam

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

…J&J, Eli Lilly and Roche have all failed large phase III trials in Alzheimer’s disease. “It’s the elephant in the room: disease-modifying trials in Alzheimer’s are all failures,” said Niels…

May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Nov 2022

‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward

…said: “These exciting findings represent a major step forward for dementia research and could herald a new era for people with Alzheimer’s disease. Lecanemab slowing the course of Alzheimer’s “Lecanemab…

November 30, 2022 - 6 minutesmins - By Liza Laws

News and Trends 19 Dec 2016

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s not over yet. Probiodrug explains the failure and response. Alzheimer’s Disease devastates families and represents…

December 19, 2016 - 7 minutesmins - By Evelyn Warner

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

…found that pathological forms of tau, rather than amyloid-beta, are indeed the key driver of Alzheimer’s disease. As the amyloid-beta hypothesis has increasingly been challenged, many players in the Alzheimer’s…

September 2, 2020 - 8 minutesmins - By Farhan Mitha

taurx tau protein tangles biotech alzheimers

News and Trends 28 Jul 2016

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

The much-anticipated results of TauRx’s Phase III trial for Alzheimer’s disease have finally been disclosed. Despite some complicated effects, this could be the first available working therapy for Alzheimer’s patients….

July 28, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Feb 2023

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

…a conversation about current drugs, clinical trials, and the pipeline. What is Alzheimer’s disease? Alzheimer’s is a brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability…

February 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 25 Jun 2018

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

…is not the only biotech who thinks that epigenetics might be a better solution to treating Alzheimer’s. Rodin Therapeutics, in partnership with Biogen, is developing an epigenetic Alzheimer’s treatment targeting…

June 25, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 12 Jun 2017

German Biotech Unveils Positive Phase II Results for Alzheimer’s

…and now we’re starting to see success.” Probiodrug’s Alzheimer’s pipeline. Drugs like Eli Lilly’s failed solanezumab, or Biogen’s Phase III Alzheimer’s asset aducanumab bind unspecifically to aggregated ABeta, explained Glund….

June 12, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 22 Nov 2017

Finnish Scientists Find Brain Cells Involved in Alzheimer’s Disease

…relationship between astrocytes and Alzheimer’s using induced pluripotent stem (iPS) cells. These cells can now be investigated as a therapeutic target of future drugs for the neurodegenerative disorder. Alzheimer’s disease…

November 22, 2017 - 3 minutesmins - By Alex Dale

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Alzheimer's

Six advancements in Alzheimer’s research over the past year

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Biogen: how is the biotech giant pivoting from a failed Alzheimer’s drug?

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Finnish Scientists Find Brain Cells Involved in Alzheimer’s Disease

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!